These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 2334912)
1. Inhibition of estradiol uptake and transforming growth factor alpha secretion in human breast cancer cell line MCF-7 by an alkyl-lysophospholipid. Kosano H; Yasutomo Y; Kugai N; Nagata N; Inagaki H; Tanaka S; Takatani O Cancer Res; 1990 Jun; 50(11):3172-5. PubMed ID: 2334912 [TBL] [Abstract][Full Text] [Related]
2. Reduction of epidermal growth factor binding in human breast cancer cell lines by an alkyl-lysophospholipid. Kosano H; Takatani O Cancer Res; 1988 Nov; 48(21):6033-6. PubMed ID: 3262419 [TBL] [Abstract][Full Text] [Related]
3. Inhibition by an alkyl-lysophospholipid of the uptake of epidermal growth factor in human breast cancer cell lines in relation to epidermal growth factor internalization. Kosano H; Takatani O Cancer Res; 1989 Jun; 49(11):2868-70. PubMed ID: 2785846 [TBL] [Abstract][Full Text] [Related]
4. Growth-inhibitory action of an estrogen-chlorambucil conjugate (KM2210) in human breast cancer cell line MCF-7: its relation to reduction of estrogen receptor and transforming growth factor-alpha secretion. Kosano H; Kubota T; Ohsawa N; Yamamori S; Abe O; Inagaki H; Nagata N Cancer Res; 1992 Mar; 52(5):1187-91. PubMed ID: 1737378 [TBL] [Abstract][Full Text] [Related]
5. Decreased sensitivity to 1-O-octadecyl-2-O-methyl-glycerophosphocholine in MCF-7 cells adapted for serum-free growth correlates with constitutive association of Raf-1 with cellular membranes. Samadder P; Arthur G Cancer Res; 1999 Oct; 59(19):4808-15. PubMed ID: 10519389 [TBL] [Abstract][Full Text] [Related]
6. Increase of transferrin binding induced by an alkyl-lysophospholipid in breast cancer cells. Kosano H; Takatani O J Lipid Mediat; 1990; 2(2):117-21. PubMed ID: 2135668 [TBL] [Abstract][Full Text] [Related]
7. Alterations in transforming growth factor-alpha and -beta production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth. Herman ME; Katzenellenbogen BS Cancer Res; 1994 Nov; 54(22):5867-74. PubMed ID: 7954416 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of growth factor-dependent inositol phosphate Ca2+ signaling by antitumor ether lipid analogues. Seewald MJ; Olsen RA; Sehgal I; Melder DC; Modest EJ; Powis G Cancer Res; 1990 Aug; 50(15):4458-63. PubMed ID: 2369723 [TBL] [Abstract][Full Text] [Related]
9. The differential susceptibility of A427 and A549 cell lines to the growth-inhibitory effects of ET-18-OCH3 does not correlate with the relative effects of the alkyl-lysophospholipid on the incorporation of fatty acids into cellular phospholipids. Lu X; Arthur G Cancer Res; 1992 May; 52(10):2813-7. PubMed ID: 1581895 [TBL] [Abstract][Full Text] [Related]
10. Different mechanisms of inhibition by alkyl-lysophospholipid and phorbol ester of granulocyte-macrophage colony-stimulating factor binding to human leukemic cell lines. Shoji M; Fukuhara T; Winton EF; Berdel WE; Vogler WR Exp Hematol; 1994 Jan; 22(1):13-8. PubMed ID: 8282054 [TBL] [Abstract][Full Text] [Related]
11. Perturbations of cellular acylation processes by the synthetic alkyl-lysophospholipid 1-O-octadecyl-2-O-methylglycero-3-phosphocholine do not correlate with inhibition of proliferation of MCF7 and T84 cell lines. Lu X; Arthur G Cancer Res; 1992 May; 52(10):2806-12. PubMed ID: 1581894 [TBL] [Abstract][Full Text] [Related]
12. Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (Edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-X(L). Mollinedo F; Fernández-Luna JL; Gajate C; Martín-Martín B; Benito A; Martínez-Dalmau R; Modolell M Cancer Res; 1997 Apr; 57(7):1320-8. PubMed ID: 9102220 [TBL] [Abstract][Full Text] [Related]
13. ET-18-OCH3 inhibits the phosphorylation and activation of p70 S6 kinase in MCF-7 cells. Arthur G; Samadder P; Bittman R Anticancer Res; 2005; 25(1A):95-100. PubMed ID: 15816524 [TBL] [Abstract][Full Text] [Related]
14. Interleukin-1 alpha and interleukin-6 act additively to inhibit growth of MCF-7 breast cancer cells in vitro. Danforth DN; Sgagias MK Cancer Res; 1993 Apr; 53(7):1538-45. PubMed ID: 8453620 [TBL] [Abstract][Full Text] [Related]
15. The antitumor ether lipid 1-Q-octadecyl-2-O-methyl-rac-glycerophosphocholine (ET-18-OCH3) inhibits the association between Ras and Raf-1. Samadder P; Richards C; Bittman R; Bhullar RP; Arthur G Anticancer Res; 2003; 23(3B):2291-5. PubMed ID: 12894505 [TBL] [Abstract][Full Text] [Related]
16. ET-18-OCH3 inhibits nuclear factor-kappa B activation by 12-O-tetradecanoylphorbol-13-acetate but not by tumor necrosis factor-alpha or interleukin 1 alpha. Daniel LW; Civoli F; Rogers MA; Smitherman PK; Raju PA; Roederer M Cancer Res; 1995 Nov; 55(21):4844-9. PubMed ID: 7585518 [TBL] [Abstract][Full Text] [Related]
17. Induction of jun gene family members by transforming growth factor alpha but not 17 beta-estradiol in human breast cancer cells. Davidson NE; Prestigiacomo LJ; Hahm HA Cancer Res; 1993 Jan; 53(2):291-7. PubMed ID: 8417822 [TBL] [Abstract][Full Text] [Related]
18. The relationship between cellular ether glycerophospholipid content and sensitivity of cancer cells to 1-O-octadecyl-2-O-methyl-glycerophosphocholine. Zhou X; Lu X; Arthur G Anticancer Res; 1992; 12(5):1659-62. PubMed ID: 1444233 [TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor alpha enhances secretion of transforming growth factor beta2 in MCF-7 breast cancer cells. Danforth DN; Sgagias MK Clin Cancer Res; 1996 May; 2(5):827-35. PubMed ID: 9816237 [TBL] [Abstract][Full Text] [Related]
20. Dissociation of the effects of the antitumour ether lipid ET-18-OCH3 on cytosolic calcium and on apoptosis. Alonso MT; Gajate C; Mollinedo F; Modolell M; Alvarez J; García-Sancho J Br J Pharmacol; 1997 Aug; 121(7):1364-8. PubMed ID: 9257915 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]